A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors (Q33401052)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors |
scientific article |
Statements
1 reference
A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors (English)
1 reference
Jaap Verweij
1 reference
Johann Sebastian De Bono
1 reference
Leni van Doorn
1 reference
Dionysis Papadatos-Pastos
1 reference
Rebecca Kristeleit
1 reference
Phillip Debnam
1 reference
Matthew Tall
1 reference
Adam Stewart
1 reference
Florence Raynaud
1 reference
Michelle Dawn Garrett
1 reference
Martin Toal
1 reference
Leon Hooftman
1 reference
Ferry Alm Eskens
1 reference
1 May 2012
1 reference
1 reference
18
1 reference
2687-2694
1 reference
Identifiers
1 reference
1 reference